FEATURED PUBLICATIONS

Usually, stable coronary artery disease is managed with the use of medication. This medication often centres on preventing myocardial infarction and death. There are also anti-anginal medications that have proven beneficial for reducing the symptoms of coronary artery disease. However, before...

Recently, many randomised controlled trials have been conducted to research the optimal medical therapy for chronic coronary syndromes. This is due to the fact that revascularisation, the original treatment, has failed to reduce rates of death, myocardial infarction or angina symptoms....

Major adverse cardiac events have been found to be associated not just with coronary obstructive lesions; this was the previous hypothesis, entitled the ischemia hypothesis or the stenosis hypothesis. It is now understood that the plaque burden along the entire coronary...

Following percutaneous coronary intervention, 20-40% of patients experience persistent or recurrent angina. This impacts patient morbidity, as well as them economically - they are often faced with recurrent hospitalisations or hospital visits, as well as higher levels of medication. Angina post-percutaneous...

There is little research into the prevalence of unrecognised myocardial infarction in patients who are undergoing percutaneous coronary intervention. Little is also known about the significance of unrecognised myocardial infarction in regard to percutaneous coronary intervention. In this study, it was...

Depression is known to be associated with a higher risk of primary and secondary cardiovascular events occurring. For example, depression is linked to a 4-fold increased risk of cardiovascular morbidity and mortality compared to those without depression. One of the reasons...

This study analysed 220 participants to understand whether Ivabradine is safe and efficacious in patients with chronic heart failure. Ivabradine is an antianginal drug, used as an alternative to beta blockers. Using this drug demonstrated improved symptoms in patients with a...

It is known that hyperglycemia can cause thrombosis and fibrinolysis. These conditions can correlate with atherosclerotic plaques forming. It is also known that high levels of leukocytes are correlated with atherosclerosis, as well as cardiovascular diseases in general. So, leukocytes are...

Ischemia with no obstructive coronary arteries, INOCA, is often found in patients suffering with angina. Yet, despite how common it is, the risk factors for being rehospitalised for chest pains with INOCA are generally unknown. This study, performed on 2,874 patients,...

Diabetes is a risk factor for cardiovascular diseases. Furthermore, patients with diabetes are highly sensitive to ischaemia/reperfusion injury, and diabetes can negatively affect cardioprotective intervention, lowering their efficacy. In particular, diabetes impairs the effect of I-Post and nicorandil, which are often...